Alkem's Daman facility passes Malta Medicines Authority inspection

Alkem Laboratories' manufacturing facility in Daman, India, underwent a GMP inspection by the Malta Medicines Authority from December 5 to December 9, 2025. The company reported that the inspection concluded with no critical observations.

The inspection identified three major observations and a few minor observations. Alkem Laboratories has committed to addressing these observations within the stipulated timeframe to ensure their closure.

The information was disclosed to both the BSE Limited and the National Stock Exchange of India Limited on December 10, 2025, by Manish Narang, president - legal, company secretary, and compliance officer.